Strategies for Enhancing Biosimilar Adoption through Education and Financial Reforms

June 29, 2025 - 17:50

Josh Canavan, PharmD, and Chris O'Dell emphasize the critical need to bridge educational gaps for both patients and healthcare providers to facilitate the widespread adoption of biosimilars. They argue that pharmacists play a pivotal role in this educational process, acting as key resources for patients seeking to understand the benefits and implications of biosimilar therapies. By enhancing communication and providing accurate information, pharmacists can help alleviate concerns and misconceptions surrounding these alternatives to biologic drugs.

Additionally, Canavan and O'Dell highlight the importance of addressing financial barriers that hinder biosimilar use. They point out that current healthcare contract structures often create disincentives for providers to prescribe these cost-effective alternatives. By reforming these financial incentives, healthcare systems can encourage more providers to consider biosimilars as viable treatment options. Together, these strategies aim to create a more supportive environment for biosimilar adoption, ultimately improving patient access to affordable and effective therapies.